[1]
|
Siegel, R.L., Giaquinto, A.N. and Jemal, A. (2024) Cancer Statistics, 2024. CA: A Cancer Journal for Clinicians, 74, 12-49. https://doi.org/10.3322/caac.21820
|
[2]
|
Chen, Z., Fillmore, C.M., Hammerman, P.S., Kim, C.F. and Wong, K. (2014) Non-Small-Cell Lung Cancers: A Heterogeneous Set of Diseases. Nature Reviews Cancer, 14, 535-546. https://doi.org/10.1038/nrc3775
|
[3]
|
Tang, J., Yu, J.X., Hubbard-Lucey, V.M., Neftelinov, S.T., Hodge, J.P. and Lin, Y. (2018) Trial Watch: The Clinical Trial Landscape for PD1/PDL1 Immune Checkpoint Inhibitors. Nature Reviews Drug Discovery, 17, 854-855. https://doi.org/10.1038/nrd.2018.210
|
[4]
|
Carbone, D.P., Reck, M., Paz-Ares, L., Creelan, B., Horn, L., Steins, M., et al. (2017) First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer. New England Journal of Medicine, 376, 2415-2426. https://doi.org/10.1056/nejmoa1613493
|
[5]
|
Wu, J.Y. and Maniatis, T. (1993) Specific Interactions between Proteins Implicated in Splice Site Selection and Regulated Alternative Splicing. Cell, 75, 1061-1070. https://doi.org/10.1016/0092-8674(93)90316-i
|
[6]
|
Cazalla, D., Newton, K. and Cáceres, J.F. (2005) A Novel Sr-Related Protein Is Required for the Second Step of Pre-mRNA Splicing. Molecular and Cellular Biology, 25, 2969-2980. https://doi.org/10.1128/mcb.25.8.2969-2980.2005
|
[7]
|
Gill, G. (2005) Something about SUMO Inhibits Transcription. Current Opinion in Genetics & Development, 15, 536-541. https://doi.org/10.1016/j.gde.2005.07.004
|
[8]
|
Li, W., Li, X., Gao, L. and You, C. (2020) Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma. Frontiers in Genetics, 11, Article No. 185. https://doi.org/10.3389/fgene.2020.00185
|
[9]
|
Wu, T., Hu, E., Xu, S., Chen, M., Guo, P., Dai, Z., et al. (2021) Clusterprofiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data. The Innovation, 2, Article ID: 100141. https://doi.org/10.1016/j.xinn.2021.100141
|
[10]
|
Zeng, D., Ye, Z., Shen, R., Yu, G., Wu, J., Xiong, Y., et al. (2021) IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures. Frontiers in Immunology, 12, Article ID: 687975. https://doi.org/10.3389/fimmu.2021.687975
|
[11]
|
Li, T., Fan, J., Wang, B., et al. (2017) TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Research, 77, e108-e110.
|
[12]
|
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., et al. (2013) Inferring Tumour Purity and Stromal and Immune Cell Admixture from Expression Data. Nature Communications, 4, Article No. 2612. https://doi.org/10.1038/ncomms3612
|
[13]
|
Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. https://doi.org/10.3322/caac.21660
|
[14]
|
Kwong, G.A., Ghosh, S., Gamboa, L., Patriotis, C., Srivastava, S. and Bhatia, S.N. (2021) Synthetic Biomarkers: A Twenty-First Century Path to Early Cancer Detection. Nature Reviews Cancer, 21, 655-668. https://doi.org/10.1038/s41568-021-00389-3
|
[15]
|
Carlino, M.S., Larkin, J. and Long, G.V. (2021) Immune Checkpoint Inhibitors in Melanoma. The Lancet, 398, 1002-1014. https://doi.org/10.1016/s0140-6736(21)01206-x
|
[16]
|
Baker, D.J., Arany, Z., Baur, J.A., Epstein, J.A. and June, C.H. (2023) CAR T Therapy Beyond Cancer: The Evolution of a Living Drug. Nature, 619, 707-715. https://doi.org/10.1038/s41586-023-06243-w
|
[17]
|
Vesely, M.D., Zhang, T. and Chen, L. (2022) Resistance Mechanisms to Anti-Pd Cancer Immunotherapy. Annual Review of Immunology, 40, 45-74. https://doi.org/10.1146/annurev-immunol-070621-030155
|
[18]
|
Perez, Y., Menascu, S., Cohen, I., Kadir, R., Basha, O., Shorer, Z., et al. (2018) RSRC1 Mutation Affects Intellect and Behaviour through Aberrant Splicing and Transcription, Downregulating IGFBP3. Brain, 141, 961-970. https://doi.org/10.1093/brain/awy045
|
[19]
|
Potkin, S.G., Turner, J.A., Fallon, J.A., Lakatos, A., Keator, D.B., Guffanti, G., et al. (2008) Gene Discovery through Imaging Genetics: Identification of Two Novel Genes Associated with Schizophrenia. Molecular Psychiatry, 14, 416-428. https://doi.org/10.1038/mp.2008.127
|
[20]
|
Yu, S., Gautam, N., Quan, M. and Gao, Y. (2019) RSRC1 Suppresses Gastric Cancer Cell Proliferation and Migration by Regulating PTEN Expression. Molecular Medicine Reports, 20, 1747-1753. https://doi.org/10.3892/mmr.2019.10409
|
[21]
|
周家田, 尚观胜, 张聪, 等. RSRC1通过靶向调控PTEN/PI3K/AKT通路抑制食管鳞状细胞癌的增殖和转移[J]. 新医学, 2023, 54(10): 749-753.
|
[22]
|
McDaniel, L.D., Conkrite, K.L., Chang, X., Capasso, M., Vaksman, Z., Oldridge, D.A., et al. (2017) Common Variants Upstream of MLF1 at 3q25 and within CPZ at 4p16 Associated with Neuroblastoma. PLOS Genetics, 13, e1006787. https://doi.org/10.1371/journal.pgen.1006787
|
[23]
|
仇玮祎. 雌激素受体共调节因子RSRC1的生物学功能研究[D]: [博士学位论文]. 北京: 中国人民解放军军事医学科学院, 2009.
|
[24]
|
Kasavi, C. (2023) Idiopathic Pulmonary Arterial Hypertension: Network-Based Integration of Multi-Omics Data Reveals New Molecular Signatures and Candidate Drugs. OMICS: A Journal of Integrative Biology, 27, 315-326. https://doi.org/10.1089/omi.2023.0066
|
[25]
|
Anderson, N.M. and Simon, M.C. (2020) The Tumor Microenvironment. Current Biology, 30, R921-R925. https://doi.org/10.1016/j.cub.2020.06.081
|
[26]
|
Brassart-Pasco, S., Brézillon, S., Brassart, B., Ramont, L., Oudart, J. and Monboisse, J.C. (2020) Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression. Frontiers in Oncology, 10, Article No. 397. https://doi.org/10.3389/fonc.2020.00397
|
[27]
|
Xu, C., Sui, S., Shang, Y., Yu, Z., Han, J., Zhang, G., et al. (2020) The Landscape of Immune Cell Infiltration and Its Clinical Implications of Pancreatic Ductal Adenocarcinoma. Journal of Advanced Research, 24, 139-148. https://doi.org/10.1016/j.jare.2020.03.009
|
[28]
|
Bagaev, A., Kotlov, N., Nomie, K., Svekolkin, V., Gafurov, A., Isaeva, O., et al. (2021) Conserved Pan-Cancer Microenvironment Subtypes Predict Response to Immunotherapy. Cancer Cell, 39, 845-865.e7. https://doi.org/10.1016/j.ccell.2021.04.014
|
[29]
|
Speiser, D.E., Chijioke, O., Schaeuble, K. and Münz, C. (2023) CD4+ T Cells in Cancer. Nature Cancer, 4, 317-329. https://doi.org/10.1038/s43018-023-00521-2
|
[30]
|
Bruni, D., Angell, H.K. and Galon, J. (2020) The Immune Contexture and Immunoscore in Cancer Prognosis and Therapeutic Efficacy. Nature Reviews Cancer, 20, 662-680. https://doi.org/10.1038/s41568-020-0285-7
|
[31]
|
Liu, J., Peng, Y. and Wei, W. (2022) Cell Cycle on the Crossroad of Tumorigenesis and Cancer Therapy. Trends in Cell Biology, 32, 30-44. https://doi.org/10.1016/j.tcb.2021.07.001
|